Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010

Oct 29, 2010, 16:00 ET from Cadence Pharmaceuticals, Inc.

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2010 financial results on Friday, November 5, 2010.

Cadence management will host a conference call and live webcast to discuss the financial results on Friday, November 5 at 5:30 am Pacific Time (8:30 am Eastern Time). Interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international).  To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investor Relations page.  A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence's pipeline, visit www.cadencepharm.com.

Contacts:

William R. LaRue


SVP & Chief Financial Officer


Cadence Pharmaceuticals, Inc.


858-436-1400



SOURCE Cadence Pharmaceuticals, Inc.



RELATED LINKS

http://www.cadencepharm.com